Haq; Rizwan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Haq; Rizwan.The latest application filed is for "biomarkers predictive of cancer cell response to ml329 or a derivative thereof".
- Haq; Rizwan - Boston MA
| Patent | Date |
|---|---|
| Biomarkers Predictive Of Cancer Cell Response To Ml329 Or A Derivative Thereof App 20220128562 - Haq; Rizwan ; et al. | 2022-04-28 |
| Biomarkers Predictive Of Anti-immune Checkpoint Response App 20210072248 - Haq; Rizwan ; et al. | 2021-03-11 |
| Combinatorial compositions and methods for treatment of melanoma Grant 9,937,161 - Haq , et al. April 10, 2 | 2018-04-10 |
| Inhibitors Of The Mitf Molecular Pathway App 20170334842 - FALOON; Patrick ; et al. | 2017-11-23 |
| Inhibitors of the MITF molecular pathway Grant 9,745,261 - Faloon , et al. August 29, 2 | 2017-08-29 |
| Inhibitors Of The Mitf Molecular Pathway App 20160130222 - FALOON; Patrick ; et al. | 2016-05-12 |
| Combinatorial Compositions And Methods For Treatment Of Melanoma App 20160008332 - HAQ; Rizwan ; et al. | 2016-01-14 |
| Method For Regulating Skin Pigmentation App 20140296223 - Fisher; David E. ; et al. | 2014-10-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 